Literature DB >> 17611315

[Effects of neuregulin on cardiac myocyte apoptosis and PI-3K signal transduction pathway in rapid pacing-induced heart failure in rhesus monkeys].

Jiang Li1, Ou Qiang, Li Wang.   

Abstract

OBJECTIVE: To explore the protective effect of neuregulin against cardiac myocyte injury in pacing-induced heart failure in rhesus monkeys and its mechanism.
METHODS: Rapid pacing was used to induce heart failure in rhesus monkeys. Aorta intubation was used to perform hemodynamic measurements such as the peak positive rate of of left ventricular pressure (LVdP/dtmax) and left ventricular systolic, end-diastolic blood pressures (LVSP and LVEDP, respectively) 17 days after the pacing. N-terminal pro-brain natriuretic peptide (BNP), as molecular marker of heart failure, was also measured by electrochemical luminescence immunoassay. The apoptosis of cardiac myocyte was observed by Tunel method. Western blot was used to detect the PKB activity and the relative amounts of Bcl-xl protein in the left ventricular free walls.
RESULTS: After the daily intravenous injection of 3microg/kg recombinated neuregulin for 10 days, LVdP/dtmax increased significantly while BNP decreased remarkably. The apoptotic index was obviously lower, and Bcl-xl and activity of PKB were higher.
CONCLUSION: Neuregulin protects against rapid pacing-induced apoptosis in heart failure in rhesus monkeys and the mechanism might be attributed to the increase of the activity of PKB and Bcl-xl protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611315

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  2 in total

Review 1.  Neuregulin as a heart failure therapy and mediator of reverse remodeling.

Authors:  Cristi L Galindo; Sergey Ryzhov; Douglas B Sawyer
Journal:  Curr Heart Fail Rep       Date:  2014-03

2.  Expression and Localization of Neuregulin-1 (Nrg1) and ErbB2/ErbB4 Receptors in Main Endocrine Organs of the Rhesus Monkey.

Authors:  Wei-Jiang Zhao
Journal:  Int J Endocrinol Metab       Date:  2013-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.